Acugrel As 150mg Tablet

Acugrel As 150mg Tablet is a dual antiplatelet therapy (DAPT) formulation designed to prevent blood clots and reduce the risk of heart attack, stroke, and other cardiovascular events. This fixed-dose combination contains two well-established antiplatelet agents that work synergistically to prevent platelet aggregation and keep arteries open.

It is commonly prescribed for:

• Patients recovering from myocardial infarction (heart attack) or ischemic stroke

• Individuals undergoing angioplasty (PCI) or stent placement

• Patients with acute coronary syndrome (ACS)

• Those with a history of transient ischemic attack (TIA) or peripheral artery disease (PAD)

• High-risk individuals requiring secondary prevention of thrombotic events

Active Ingredients and Their Actions:

• Aspirin 75 mg: A COX inhibitor that prevents the production of thromboxane A2, a substance that causes platelets to clump together, thus reducing the risk of blood clot formation.

• Clopidogrel 150 mg: A P2Y12 receptor antagonist that provides a stronger antiplatelet effect than the standard 75 mg dose, especially beneficial in high-risk or resistant cases.

The increased dose of clopidogrel (150 mg) is often used in:

• Patients with high platelet reactivity

• Diabetic patients who may be less responsive to standard clopidogrel doses

• Those needing more aggressive blood thinning post-stenting